These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37757824)

  • 1. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
    Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
    Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of pharmacogenetic variation in nine biogeographic groups.
    Hernandez S; Hindorff LA; Morales J; Ramos EM; Manolio TA
    Clin Transl Sci; 2024 Sep; 17(9):e70017. PubMed ID: 39206687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Turner AJ; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2024 Oct; 26(10):851-863. PubMed ID: 39032821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.
    Huddart R; Fohner AE; Whirl-Carrillo M; Wojcik GL; Gignoux CR; Popejoy AB; Bustamante CD; Altman RB; Klein TE
    Clin Pharmacol Ther; 2019 May; 105(5):1256-1262. PubMed ID: 30506572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
    Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR
    Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Variation among Pharmacogenes in the Sardinian Population.
    Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PharmGKB: A worldwide resource for pharmacogenomic information.
    Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE
    Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.
    Samarasinghe SR; Lee SB; Corpas M; Fatumo S; Guchelaar HJ; Nagaraj SH
    Clin Pharmacol Ther; 2024 Oct; 116(4):980-995. PubMed ID: 38837390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis.
    Lenz C; Narang A; Bousman CA
    Pharmacogenet Genomics; 2024 Jun; 34(4):130-134. PubMed ID: 38359167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
    Alshabeeb MA; Alyabsi M; Paras B
    Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation.
    Mauleekoonphairoj J; Chamnanphon M; Khongphatthanayothin A; Sutjaporn B; Wandee P; Poovorawan Y; Nademanee K; Pongpanich M; Chariyavilaskul P
    Sci Rep; 2020 Nov; 10(1):18969. PubMed ID: 33144648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences.
    Sherman CA; Claw KG; Lee SB
    Sci Rep; 2024 Oct; 14(1):22774. PubMed ID: 39354004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.